Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UMLS:C0022568 (
keratitis
)
5,133
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Pseudomonas aeruginosa
is a Gram negative pathogenic bacterium involved in many human infections including otitis,
keratitis
, pneumonia, and
diabetic foot ulcers
.
P. aeruginosa
uses a communication system, referred to as quorum sensing (QS), to adopt a group behavior by synchronizing the expression of certain genes. Among the regulated traits, secretion of proteases or siderophores, motility and biofilm formation are mainly involved in the pathogenicity. Many efforts have been dedicated to the development of quorum sensing inhibitors (QSI) and quorum quenching (QQ) agents to disrupt QS. QQ enzymes have been particularly considered as they may act in a catalytic way without entering the cell. Here we focus on the lactonase
Sso
Pox which was previously investigated for its ability to degrade the signaling molecules, acyl-homoserine lactones, in particular on the engineered variant
Sso
Pox-W263I. We highlight the potential of
Sso
Pox-W263I to inhibit the virulence of 51 clinical
P. aeruginosa
isolates from
diabetic foot ulcers
by decreasing the secretion of two virulence factors, proteases and pyocyanin, as well as biofilm formation. We further compared the effect of
Sso
Pox-W263I to the comprehensively described QSI, 5-fluorouracil and C-30. We found the lactonase
Sso
Pox-W263I to be significantly more effective than the tested QSI at their respective concentration optimum and to retain its activity after immobilization steps, paving the way for future therapeutic applications.
...
PMID:Effect of Quorum Quenching Lactonase in Clinical Isolates of
Pseudomonas aeruginosa
and Comparison with Quorum Sensing Inhibitors. 2826 Nov 83
